Australia Osteoporosis Drugs Market Analysis


  • Type: Common Disease Area
  • Published : April 2021
  • Region: APAC
  • Country: Australia
  • Report ID : 4122

  • Format: PPT, PDF

Australian Osteoporosis Drugs Market: Segmented by Drug Class (Bisphosphonates, Selective Estrogenic Inhibitors Modulator (SERM), Parathyroid Hormone Therapy, Calcitonin, Rank Ligand Inhibitors, & Others), by Distribution (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, & Others)- Growth, Trends, and Forecasts (2019 – 2028)


Report Overview

The Australian Osteoporosis Drugs market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Osteoporosis (meaning ‘porous bones) is a condition that causes bones to become thin, weak, and fragile. As a result, even a minor bump or accident can cause a fracture (broken bone). Such events might include falling out of a bed or chair or tripping and falling while walking. An estimated 924,000 Australians have osteoporosis, based on self-reported data from the Australian Bureau of Statistics (ABS) 2017–18 National Health Survey (NHS), and 20% of people aged 75 years and over have osteoporosis (ABS 2018). This definition of osteoporosis includes people who had osteoporosis or osteopenia. Osteoporosis is more common in women than men. In 2017–18, 29% of women aged 75 and over had osteoporosis compared with 10% of men. Older age groups also tend to be affected. The proportion of women with osteoporosis increases with age, with those 75 and over being most affected.

Market Drivers

Rising expenditure in the discovery and development of drugs to treat osteoporosis is also a major factor driving the growth of the osteoporosis drug market. The rapid pace of urbanization giving rise to unhealthy lifestyles and eating habits, which are expected to lead to a greater number of people being impacted by this disease, thereby driving the growth of the osteoporosis drug market. Rising demand for better osteoporotic care, coupled with increasing awareness about the availability of drugs for treating the disease, is pushing market players to work in the drug development area for this indication. The market players are collaborating with patient organizations, government research organizations, and academic institutes to advance their drug development activities. All these factors are expected to drive market growth in the coming years. Due to the increase in R&D investment from major players in advanced novel bisphosphonate drugs, bisphosphonates acquired the major share in the osteoporosis market. Furthermore, other factors that boost the growth of the osteoporosis drug market are a surge in the geriatric population and a rise in the adoption of sedentary lifestyles.

Major Osteoporosis Diseases

Based on disease indication, the osteoporosis drug market can be segmented into primary and secondary osteoporosis. Primary osteoporosis is the most common form of the disease and includes postmenopausal osteoporosis (type I), and senile osteoporosis (type II) and is defined as a pathological unbalancing of bone resorption and formation that leads to persistent deficits of bone mass, which ultimately translates into increased fracture susceptibility.

Secondary osteoporosis is characterized as having a clearly definable etiologic mechanism. Secondary osteoporosis results from specific clinical disorders that are potentially reversible. Up to 30% of postmenopausal women and 50% of men with osteoporosis may have an underlying cause. The underlying pathogenesis of secondary osteoporosis is often multifactorial.

1. Australian Osteoporosis Drugs Market Overview…………………………………………..
A. Market Size
2. Market Growth Drivers…………………………………………….……………………….
A. Rise in Prevalence of Osteoporosis Drugs
B. Increasing Geriatric Population & Rapid Pace of Urbanization
C. Growing R&D Investments
3. Major Osteoporosis Diseases……….………………………………………………….…
A. Primary Osteoporosis
B. Secondary Osteoporosis
4. Osteoporosis Drugs Market Segmentation………………………………………………..
A. Drug Class
I. Bisphosphonates
II. Selective Estrogenic Inhibitors Modulator (SERM)
III. Parathyroid Hormone Therapy
IV. Calcitonin
V. Rank Ligand Inhibitors
VI. Others
B. Distribution
I. Hospital Pharmacies
II. Retail Pharmacies
III. Online Pharmacies
IV. Others
5. Osteoporosis Drugs Major Products Market Share…………………….…………
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape……………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles………………………………………………………………….
A. F. Hoffmann-La Roche Diagnostics overview, Product & Services, Strategies & Financials
B. Amgen, Inc Company overview, Product & Services, Strategies & Financials
C. Merck & Co., Inc. overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape……………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth…………………………………………………………
A. New Trends and Development of Osteoporosis Drugs Market
B. Future Opportunities
10. Conclusion


Market Segmentation

By Drug Class:

Based on the drug class, the osteoporosis drug market includes bisphosphonates, selective estrogenic receptor modulator, RANKL, and others. Bisphosphonates are dominating the growth of the market as these are considered the first line of osteoporosis treatment. Furthermore, drugs containing bisphosphonates help in the reduction of bone loss by decreasing osteoclast activity. Additionally, the parathyroid hormone helps in stimulating cells that form new bones hence are widely used for patients suffering from multiple fractures. The launch of new SERMs and RANKL drug class product, such as Prolia, and arzofiene increase bone mineral density are also propagating the growth of the market.

Rank ligand inhibitors are expected to grow at a lucrative CAGR during the forecast period. The high growth potential attained is a consequence of positive patient outcomes associated with rank ligand inhibitors. The positive patient outcomes can be attributed to significant improvements in bone metabolism. Other benefits of rank ligand Inhibitors such as reduced cell bone turnover and increased bone mineral density, thereby implicating high demand.

By Distribution:

Based on the distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and stores, and online pharmacies. A rise in several patients visiting the hospitals for the treatment of osteoporosis, active government support towards hospital pharmacy development, and other factors are fuelling the growth of hospital pharmacies. Furthermore, the retail pharmacies and stores segment is expected to experience wider growth owing to an increase in partnership with orthopedic centers. Moreover, other distribution channels such as online pharmacies are anticipated to boost the growth owing to online drug purchases.

Major Players

The osteoporosis drugs market is highly competitive, and the prominent players in the market have adopted various strategies to garner maximum market share. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market include Amgen, Inc., F. Hoffmann-La Roche Ltd, GlaxoSmithKline PLC (GSK), Merck & Co., Inc., Novartis AG, Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Allergan PLC, & Eli Lilly, and Company.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements